Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome

Nai Wen Tsai, Lian Hui Lee, Chi Ren Huang, Wen Neng Chang, Ya Ting Chang, Yu Jih Su, Yi Fang Chiang, Hung Chen Wang, Ben Chung Cheng, Wei Che Lin, Chia Te Kung, Chih Min Su, Yu Jun Lin, Cheng Hsien Lu*

*Corresponding author for this work

Research output: Contribution to journalJournal Article peer-review

33 Scopus citations

Abstract

Introduction: Statins are reported to have anti-inflammatory and anti-oxidative effects aside from cholesterol-lowering effects. This study aimed to evaluate the effects of statin therapy on oxidized LDL (Ox-LDL) and the clinical outcome of patients with acute ischemic stroke (AIS).Methods: This prospective study enrolled 120 patients with AIS divided in the statin (n = 55) and non-statin (n = 65) groups. Eighty sex- and age- matched participants were recruited as risk controls. Ox-LDL was measured using a monoclonal antibody-based enzyme-linked immune-sorbent assay at different time points after AIS. The clinical outcomes were analyzed between the statin and non-statin groups.Results: Plasma Ox-LDL was significantly higher in stroke patients than in the controls (P < 0.001). Plasma Ox-LDL level was significantly reduced in the statin group on day 7 and day 30 compared to the non-statin group (P < 0.01). The plasma Ox-LDL positively correlated with serum total cholesterol, LDL-cholesterol, and hemoglobin A1c (HbA1c). Among the potential risk factors, only National Institutes of Health stroke scale (NIHSS) score and Ox-LDL level on admission were independently associated with 3-month outcome.Conclusions: Our study demonstrates that statin therapy reduces plasma Ox-LDL level after AIS. Plasma Ox-LDL may be a more powerful predictor than serum LDL, high-sensitivity C-reactive protein or white blood cell counts for stroke outcome. Therefore, assay of plasma Ox-LDL should be added as a predictor among the panel of conventional biomarkers in stroke outcome.

Original languageEnglish
Article numberR16
JournalCritical Care
Volume18
Issue number1
DOIs
StatePublished - 14 01 2014

Fingerprint

Dive into the research topics of 'Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcome'. Together they form a unique fingerprint.

Cite this